Evidence map›Paper›PMID 38674695›Full record

ArticleMicroorganisms2024

Resistome Analysis of

Jack M Blaikie, Sylvia A Sapula, Naomi L Siderius, Bradley J Hart, Anteneh Amsalu, Lex E X Leong, Morgyn S Warner, Henrietta Venter

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Multidrug-ResistantMicroorganisms · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Jack M BlaikieUniSA Clinical and Health Sciences, Health and Biomedical Innovation, University of South Australia, Adelaide, SA 5000, Australia.ORCID 0000-0002-4874-7870
Sylvia A SapulaUniSA Clinical and Health Sciences, Health and Biomedical Innovation, University of South Australia, Adelaide, SA 5000, Australia.ORCID 0000-0002-5534-9774
Naomi L SideriusUniSA Clinical and Health Sciences, Health and Biomedical Innovation, University of South Australia, Adelaide, SA 5000, Australia.ORCID 0000-0002-3265-7942
Bradley J HartUniSA Clinical and Health Sciences, Health and Biomedical Innovation, University of South Australia, Adelaide, SA 5000, Australia.
Anteneh AmsaluUniSA Clinical and Health Sciences, Health and Biomedical Innovation, University of South Australia, Adelaide, SA 5000, Australia.
Lex E X LeongUniSA Clinical and Health Sciences, Health and Biomedical Innovation, University of South Australia, Adelaide, SA 5000, Australia.
Morgyn S WarnerMicrobiology and Infectious Diseases, SA Pathology, Adelaide, SA 5000, Australia.ORCID 0000-0002-4053-1610
Henrietta VenterUniSA Clinical and Health Sciences, Health and Biomedical Innovation, University of South Australia, Adelaide, SA 5000, Australia.ORCID 0000-0001-5569-7755
University of South Australia · AUSouth Australia Pathology · AU

Funding

Medical Research Future Fund GN1152556
6 · The paper itself

Abstract

Antimicrobial-resistant

Indexed as

antimicrobial resistancebiocide resistanceceftazidimeciprofloxacinclonal disseminationmultidrug resistancewastewater-based epidemiology

Identifiers

PMID38674695
PMCPMC11051875
OpenAlexW4394580600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.